Related Experiment Video
Updated: May 13, 2026
10:20
In vitro Measurements of Tracheal Constriction Using Mice
Published on: June 25, 2012
Targeting TRP channels in airway disorders
Katharine Abbott-Banner1, Christopher Poll, J Martin Verkuyl
1Verona Pharma plc, London, UK. kathy.banner@veronapharma.com
Current Topics in Medicinal Chemistry
|March 20, 2013
Summary
Transient Receptor Potential (TRP) channels are key players in respiratory diseases. Modulating TRP channel function offers a promising therapeutic strategy for common respiratory conditions like asthma and COPD.
Area of Science:
- Physiology
- Pharmacology
- Respiratory Medicine
Background:
- Respiratory diseases impact millions globally, necessitating novel therapeutics.
- Transient Receptor Potential (TRP) channels are vital sensors in the respiratory tract, responding to various stimuli.
- Altered TRP channel function and expression are implicated in respiratory disease pathogenesis.
Purpose of the Study:
- To review evidence on TRP channel modulators for respiratory diseases.
- To focus on TRP channel's role in common, overlapping respiratory disease features.
- To discuss therapeutic potential, clinical status, and challenges of TRP channel modulators.
Main Methods:
- Literature review of TRP channel function in respiratory diseases.
- Analysis of TRP channel involvement in key pathological features.
- Examination of therapeutic strategies and clinical progress.
Main Results:
- TRP channels are implicated in bronchoconstriction, airway hyper-responsiveness, cough, inflammation, and mucus secretion.
- Evidence suggests TRP channel modulation can impact hypoxia, lung injury, and airway remodeling.
- Several TRP channel modulators are under investigation for respiratory conditions.
Conclusions:
- TRP channel modulators represent a potential therapeutic avenue for diverse respiratory diseases.
- Targeting shared pathological mechanisms via TRP channels could offer broad clinical benefits.
- Further research and clinical trials are needed to overcome challenges in this field.
Related Concept Videos
01:22Trachea
The trachea, commonly known as the windpipe, is a vital part of the human respiratory system. It serves as a passageway for air to travel between the larynx and the bronchi, allowing oxygen to reach the lungs. Let's explore its anatomical features, dimensions, layers of the tracheal wall, associated muscles, and the functions of its parts.
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
Anatomical Features:
Location: About half of the trachea is situated in the neck, anterior to the esophagus, and extends from the larynx (at the level of the...
01:17Drugs Used in Lower Respiratory Disorders: Overview
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:20Antiasthma Drugs: Muscarinic Receptor Antagonists
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...